Strensiq (asfotase alfa)

pCPA File Number: 20936

Negotiation Status:

Concluded without agreement

Indication(s):

Pediatric-onset hypophosphatasia

Sponsor/Manufacturer:

Alexion Pharma GmbH

CDA-AMC Project Number:

SR0443-000

pCPA Engagement Letter Issued:

2016-06-30

Negotiation Process Concluded:

2017-02-09